Colin Broom M.D., Director at Nabriva Therapeutics plc (NBRV), bought 10,177 shares at $2.03 ($21K) on 2019-08-30, disclosed to the SEC on 2019-09-03.
Open-market purchase of $21k NBRV by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| NBRV | SELL | 2020-08-21 | $7K | — | Filing → |
| NBRV | BUY | 2018-06-25 | $19K | — | Filing → |
| NBRV | BUY | 2018-05-23 | $46K | — | Filing → |